Related Experiment Video
Updated: Aug 25, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
[Linezolid (Zyvoxid)]
1Services des Maladies Infectieuses, CHU Saint-Pierre, ULB, Bruxelles.
Abstract:
Linezolid is a novel antibiotic administrable by the intravenous as well as the oral route. It is aimed by its re-imbursement conditions at treating proven beta-lactam- or glycopeptide-resistant staphylococcal and enterococcal infections in the hospital and post-discharge outpatient. It has various indications: pulmonary infections, complicated skin and soft tissue infections, infections in the febrile neutropenic patient, urinary tract infections, intra-abdominal infections, chronic osteitis. Bacteriologic documentation of the infection is required to avoid overconsumption and development of resistance. The oral forms exhibit complete bio-availability. Caution is recommended with regard to linezolid's MAO inhibitory effect and the risk of thrombocytopenia requiring weekly hematologic monitoring.
Insights
Linezolid is an effective antibiotic for resistant bacterial infections, available orally and intravenously. Careful monitoring is advised due to potential side effects like thrombocytopenia.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Context:
- Linezolid is a novel oxazolidinone antibiotic.
- It targets resistant Gram-positive bacteria, including staphylococci and enterococci.
- Approved for hospital and outpatient treatment of specific infections.
Purpose:
- To outline the indications and administration of linezolid.
- To emphasize the need for bacteriologic documentation to prevent resistance.
- To highlight key safety considerations and monitoring requirements.
Summary:
- Linezolid offers intravenous and oral administration for proven beta-lactam- or glycopeptide-resistant staphylococcal and enterococcal infections.
- Indications include pulmonary, skin, soft tissue, urinary tract, intra-abdominal infections, febrile neutropenia, and chronic osteitis.
- Complete oral bioavailability and MAO inhibitory effects necessitate caution and weekly hematologic monitoring for thrombocytopenia.
Impact:
- Facilitates treatment of challenging resistant bacterial infections.
- Provides a crucial therapeutic option for both inpatient and outpatient settings.
- Highlights the importance of antimicrobial stewardship and patient monitoring for safe and effective use.
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Antiprotozoal Agents
Antimicrobial Effectiveness
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Subviral Agents
Antifungal Agents
